Cerity Partners LLC Has $14.51 Million Stock Holdings in Maximus, Inc. $MMS

Cerity Partners LLC boosted its position in shares of Maximus, Inc. (NYSE:MMS) by 67.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 206,683 shares of the health services provider’s stock after acquiring an additional 83,410 shares during the period. Cerity Partners LLC owned approximately 0.37% of Maximus worth $14,509,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Savant Capital LLC lifted its position in shares of Maximus by 84.1% during the 2nd quarter. Savant Capital LLC now owns 10,055 shares of the health services provider’s stock worth $706,000 after buying an additional 4,594 shares during the period. Magnetar Financial LLC grew its position in Maximus by 123.5% in the second quarter. Magnetar Financial LLC now owns 12,774 shares of the health services provider’s stock valued at $897,000 after acquiring an additional 7,059 shares during the period. Bank of New York Mellon Corp raised its stake in Maximus by 1.6% during the second quarter. Bank of New York Mellon Corp now owns 549,369 shares of the health services provider’s stock worth $38,566,000 after acquiring an additional 8,434 shares in the last quarter. Boston Partners raised its stake in Maximus by 113.6% during the second quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock worth $46,435,000 after acquiring an additional 349,529 shares in the last quarter. Finally, AlphaQuest LLC lifted its holdings in shares of Maximus by 142.0% during the second quarter. AlphaQuest LLC now owns 8,663 shares of the health services provider’s stock valued at $608,000 after acquiring an additional 5,083 shares during the period. Institutional investors own 97.21% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on MMS shares. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a report on Monday. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.00.

Insider Buying and Selling at Maximus

In related news, insider Michelle F. Link sold 4,039 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the completion of the transaction, the insider owned 19,542 shares in the company, valued at $1,697,027.28. The trade was a 17.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Maximus Stock Performance

Shares of NYSE:MMS opened at $81.88 on Wednesday. The business has a fifty day moving average of $85.12 and a 200-day moving average of $80.55. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.64 and a current ratio of 1.64. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $92.50. The firm has a market cap of $4.46 billion, a PE ratio of 14.73 and a beta of 0.56.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.01). The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter last year, the company earned $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.5%. Maximus’s dividend payout ratio (DPR) is currently 21.58%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.